Notify me when Phillip Frost files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| OPK | OPKO HEALTH, INC. | Common Stock, par value $0.01 per share | 32.8% | $352M | $674K | 253M | +0.19% | FROST PHILLIP MD ET AL | Sep 30, 2025 |
| FLNT | Fluent, Inc. | Common Stock, par value $0.0005 per share | 28.3% | $17.6M | $1.38M | 7.3M | +8.49% | Phillip Frost, M.D. | Aug 19, 2025 |
| COCP | Cocrystal Pharma, Inc. | Common Stock, par value $0.001 per share | 17.8% | $3.08M | $1.35M | 2.46M | +78% | Phillip Frost, M.D. | Oct 28, 2025 |
| NOCOPI TECHNOLOGIES INC/MD/ | Common stock of the Company, par value $0.01 per share ("Common Shares") | 13.6% | 1.47M | Phillip Frost, M.D. | Jun 6, 2025 | ||||
| DOUG | Douglas Elliman Inc. | Common Stock, par value $0.01 per share | 8.6% | $13.1M | 7.65M | Phillip Frost, M.D. | Jan 1, 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
|---|